Atossa Therapeutics Successfully Fills ZEndoxifen Segment of ISPY 2 Clinical Trial
As of February 7, 2024, Atossa Therapeutics has successfully filled the (Z)-endoxifen segment of the I-SPY 2 clinical trial. This ...
As of February 7, 2024, Atossa Therapeutics has successfully filled the (Z)-endoxifen segment of the I-SPY 2 clinical trial. This ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.